Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of 8:00pm ET
 -0.44 / -0.63%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+9.59% 3 years+11.06%
3 months+4.41% 5 years+22.11%
1 year+36.41% Since inception+14.30%
Data through 02/18/2017

Quote Details

Previous close$69.45
Open day’s range68.83 – 69.92
Net asset value (NAV)69.49 (02/17/2017)
Daily volume3,554,598
Average volume (3 months)6,371,513
Data as of 8:00pm ET, 02/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.11%+16.84%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.781.06
Net assets$2.6B$2.8B
Average market cap$4.5B$29.2B
Average P/E--21.1
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 3.98%
CLVS Clovis Oncology Inc3.76%
ACAD ACADIA Pharmaceuticals Inc2.74%
UTHR United Therapeutics Corp2.63%
EXAS Exact Sciences Corp2.60%
INCY Incyte Corp2.55%
VRTX Vertex Pharmaceuticals Inc2.37%
KITE Kite Pharma Inc2.35%
AMGN Amgen2.31%